APA (7th ed.) Citation

AF, S., TP, T., CJ, H., MS, B., C, C., RE, O., . . . RS, O. (2018). Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189. ACS medicinal chemistry letters, 9(2), 68. https://doi.org/10.1021/acsmedchemlett.7b00343

Chicago Style (17th ed.) Citation

AF, Stepan, et al. "Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189." ACS Medicinal Chemistry Letters 9, no. 2 (2018): 68. https://doi.org/10.1021/acsmedchemlett.7b00343.

MLA (9th ed.) Citation

AF, Stepan, et al. "Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189." ACS Medicinal Chemistry Letters, vol. 9, no. 2, 2018, p. 68, https://doi.org/10.1021/acsmedchemlett.7b00343.